Asserting Internet marketing Approval for Hunterase ICV Injection 15 mg, the World’s First Enzyme Substitute Treatment for Mucopolysaccharidosis Type II (Hunter Syndrome) Administered by ICV Injection
GC Pharma (previously recognised as Inexperienced Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical business, and Clinigen K.K. ("Clinigen"), headquartered...
